Depression Clinical Trials in Chicago, Illinois

13 studies are recruiting for depression in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

    The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD. For more information about the EMBRACE study, including participating study locations, and to register your interest in learning more …

    Stage
    Phase 3
    Ages
    18 to 85
    Site
    Rush University, Chicago, Illinois
    Locations
    69 in total
    Run by
    Cybin IRL Limited
  2. Cognitive Training as an Adjunct to Ketamine in Real-world Clinics

    In a sample of patients already receiving ketamine (or esketamine) treatment as part of their clinical care, this project seeks to test whether we can enhance and/or extend (es)ketamine's rapid effects by introducing helpful information delivered by a computer-based cognitive training protocol. Thi…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    University of Illinois at Chicago, Chicago, Illinois
    Locations
    3 in total
    Run by
    University of Pittsburgh
  3. Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older

    The goal of this randomized clinical trial is to test the efficacy of a fully digital intervention, combining the Lumen problem-solving therapy virtual coach for depression management with the Diabetes Prevention Program video-based program for weight loss, among racial and ethnic minorities with c…

    Stage
    Not phased
    Ages
    50 to 74
    Site
    Department of Medicine, Vitoux Program on Aging and Prevention, Chicago, Illinois
    Locations
    2 in total
    Run by
    University of Illinois at Chicago
  4. E-Mindfulness Approaches for Living After Breast Cancer

    NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants wi…

    Stage
    Phase 3
    Ages
    18 to 50
    Site
    Northwestern University, Chicago, Illinois
    Locations
    383 in total
    Run by
    NRG Oncology
  5. A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

    Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. The treatment of the depressive episodes of bipolar disorder in the pediatric population has not been as widely studied as the treatment of dep…

    Stage
    Phase 3
    Ages
    10 to 17
    Site
    Duplicate_Ascension St. Elizabeth /ID# 240772, Chicago, Illinois
    Locations
    81 in total
    Run by
    AbbVie
  6. Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury

    This is a feasibility trial of a digital mental health intervention aimed at adolescents (ages 14-18) with nonsuicidal self-injury and who are not currently engaged in mental health treatment. The study has two arms: a self-guided DMHI and an active control which will involve the delivery of non-in…

    Stage
    Not phased
    Ages
    14 to 18
    Site
    Northwestern University, Chicago, Illinois
    Run by
    Northwestern University
  7. Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression

    The goal of this study is to find out if the antihistamine, clemastine, can make the white matter in the brain better in older adults with depression. The study will also determine whether this improvement can make antidepressant treatment work better, reduce depressive symptoms, and improve memory…

    Stage
    Phase 2
    Ages
    60 and older
    Site
    University of Illinois College of Medicine, Chicago, Illinois
    Run by
    University of Illinois at Chicago
  8. A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

    The goal of this clinical trial is to learn if a drug called TNX-102 SL works to treat moderate to severe major depressive disorder in adults. It will also learn about the safety of TNX-102 SL. The main questions it aims to answer are: Does TNX-102 SL improve depression symptoms according to a depr…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Chicago Research Center, Chicago, Illinois
    Locations
    25 in total
    Run by
    Tonix Pharmaceuticals, Inc.
  9. Effects of Transcutaneous Vagal Nerve Stimulation on Post-Surgical Return to Consciousness, Delirium, and Depression

    This study will examine whether noninvasive, transcutaneous vagal nerve stimulation (tcVNS) can help restore consciousness in patients in the operating room and the Post Anesthesia Care Unit (PACU). The study will also investigate if tcVNS can expedite discharge from the PACU and examine whether tc…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Northwestern University Feinberg School of Medicine, Chicago, Illinois
    Run by
    Northwestern University
  10. Community-based Approach to Lowering Stress Through Mindfulness

    The goal of this clinical trial is to test a culturally adapted mindfulness-based stress reduction intervention in a community setting for African American adults with high blood pressure (hypertension) and depression. The main questions it aims to answer are: * Does participation in a culturally a…

    Stage
    Not phased
    Ages
    18 and older
    Site
    The Salvation Army Ray and Joan Kroc Corps Community Center Chicago, Chicago, Illinois
    Run by
    Northwestern University
  11. ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression

    The purpose of this study is to understand how a psychotropic medication called guanfacine affects brain network functioning in humans, and how this function interacts with cognitive impairments in people experiencing depressive symptoms.

    Stage
    Phase 2
    Ages
    18 to 60
    Site
    University of Illinois at Chicago, Chicago, Illinois
    Locations
    2 in total
    Run by
    Stanford University
  12. Hybrid Type 1 Randomized Pilot Trial of a Peer-led Family and Social Strengthening Group Intervention for Refugee Families

    The proposed study draws on prior research to evaluate the feasibility, acceptability and explore preliminary effectiveness of Coffee and Family Education and Support, Version (CAFES2) using a pilot randomized type 1 hybrid effectiveness-implementation design. CAFES2 is a peer-led family and social…

    Stage
    Not phased
    Ages
    12 to 55
    Site
    University of Illinios Chicago, Chicago, Illinois
    Run by
    University of Illinois at Chicago
  13. Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. Veterans

    This research study is being done to investigate if the GH Method exercise program positively affects body composition, improves physical abilities and can improve the overall sense of wellbeing (e.g. depression, PTSD, etc.) in U.S. Veterans. Subjects will be asked to complete 94 total visits (four…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Illinois at Chicago, Chicago, Illinois
    Run by
    University of Illinois at Chicago

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.